Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Revenue: 2020-2025

Historic Revenue for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $126.0 million.

  • Cellebrite DI's Revenue rose 17.94% to $126.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $455.9 million, marking a year-over-year increase of 18.37%. This contributed to the annual value of $401.2 million for FY2024, which is 23.41% up from last year.
  • Cellebrite DI's Revenue amounted to $126.0 million in Q3 2025, which was up 11.26% from $113.3 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Revenue ranged from a high of $126.0 million in Q3 2025 and a low of $53.3 million during Q1 2021.
  • Moreover, its 3-year median value for Revenue was $95.7 million (2024), whereas its average is $97.6 million.
  • Data for Cellebrite DI's Revenue shows a peak YoY increased of 26.94% (in 2024) over the last 5 years.
  • Over the past 5 years, Cellebrite DI's Revenue (Quarterly) stood at $67.9 million in 2021, then grew by 9.00% to $74.0 million in 2022, then rose by 25.66% to $93.0 million in 2023, then increased by 17.24% to $109.0 million in 2024, then rose by 17.94% to $126.0 million in 2025.
  • Its Revenue was $126.0 million in Q3 2025, compared to $113.3 million in Q2 2025 and $107.5 million in Q1 2025.